Supreme Court’s ruling in TC Heartland v. Kraft Food on venue seen having marginal but meaningful impact on nuisance suits

The U.S. Supreme Court’s decision in TC Heartland v. Kraft Food is expected to reduce the concentration of nuisance patent infringement lawsuits especially in the perceived patent owner friendly Eastern District of Texas, though it also will increase the number of cases in jurisdictions with much less patent experience. Patent market observers say the impact [...]

May 25th, 2017|Categories: litigation, Patent Investing, Patent Trolling, Supreme Court|Tags: , |

Voip-Pal paints a David and Goliath patent struggle against Apple, AT&T and others in letter to PTAB’s Chief Judge and other policymakers

Dr. Thomas Sawyer, a Sandy, Utah-based patent investor who has served four different U.S. presidents including Richard Nixon, Gerald Ford, Ronald Reagan and George H.W. Bush, is convinced that the America Invents Act has done grievous harm to the U.S. patent market in general and in particular to Voip-Pal Inc. (VPLN), the patent licensing company [...]

May 25th, 2017|Categories: litigation, Patent Investing, PTAB|Tags: , |

Spherix, down to its last $210K, files to raise $3M for working capital, corporate purposes

Spherix Inc. (SPEX), the patent monetization company that turned over management its enforcement campaigns to Dean Becker’s Equitable IP Holdings Corp., has filed with the Securities and Exchange Commission to raise about $3 million by selling 3 million shares of common stock to be used for working capital and general corporate purposes. Shares of Spherix [...]

May 24th, 2017|Categories: Financing, Patent Investing|Tags: , |

PTAB invalidates key claims of patent supporting Valeant’s Apriso drug for ulcerative colitis

The Patent Trial and Appeal Board on May 19 invalidated the only two independent claims of a patent supporting Valeant Pharmaceuticals International Inc. (VRX)’s drug Apriso, which is a treatment for maintenance of remission of ulcerative colitis and is expected to produce about $120 million in earnings before income tax depreciation and amortization in 2018. [...]

May 24th, 2017|Categories: drug patents, Patent Investing, PTAB|Tags: , |

Acacia says its up to $50M investment in Veritone has converted into stock worth more than $53.6M

Acacia Research Corp. (ACTG), the patent licensing company run by Executive Chairman Louis Graziadio III, said it has more than made good on its pledge to invest up to $50 million in Veritone Inc. (VERI), the artificial intelligence firm upon whose board Acacia’s chairman also sits. Newport Beach California-based Acacia said in a filing with [...]

May 24th, 2017|Categories: Financing, Patent Investing|Tags: , |